Jean-Pierre Routy, MD, FRCPC
Vaccines and Immunotherapies Core Co-Leader
Chair, Steering Committee
Dr. Jean-Pierre Routy is a senior scientist in the Infectious Diseases and Immunity in Global Health Program at the McGill University Health Centre and a physician at the Royal Victoria Hospital in Montreal. He is a professor in the Division of Haematology of the Faculty of Medicine at McGill University and holds the Louis Lowenstein Chair in Hematology & Oncology and is also the Clinical Director of the Chronic Viral Illness Service. Dr Routy is also the Director of the Réseau SIDA et maladies infectieuses FRQ-S. He served as co-chair of the International AIDS Society’s International Scientific Working Group in 2012 and is a member of the HIV/AIDS Research Advisory Committee for the Federal Government of Canada. Dr. Routy is a Co-leader of the CTN’s Vaccines and Immunotherapies Core.
He earned his medical degree at the Université d’Aix-Marseille in France and completed residencies at the Hôtel-Dieu de Montréal, Hôtel-Dieu de Paris, and the Centre Hospitalier Général d’Aix-en-Provence. He has also completed diplomas and obtained professional certifications from McGill University and the Royal College of Physicians and Surgeons of Canada. Dr. Routy was one of the first recipients of a CTN Postdoctoral Fellowship.
His research focuses on HIV pathogenesis aiming at finding an HIV cure, with a particular focus on improving knowledge of immune tolerance.
In CTNPT 027, Dr. Routy and his team are evaluating the ability of metformin, a drug used to treat type 2 diabetes, to improve immune function and reduce the size of the HIV viral reservoir. In CTN 257, he is assessing the impact of HIV and antiretroviral therapy on mucosal and systemic memory CD4 T cells, with the aim of generating data to better understand how HIV harms the body and how future HIV therapies and vaccines should be designed. Dr. Routy is a co-investigator for CTN 247, the Canadian cohort of HIV+ slow progressors, whose objective is to gain a better understanding of various factors affecting the slow progression of HIV in certain individuals. He is also leading CTN 298 and CTNPT 032 CTN 038.
Dr. Routy is a prolific writer and has contributed to over 100 CTN research publications since 2008.
